دورية أكاديمية

Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two‐centre study.

التفاصيل البيبلوغرافية
العنوان: Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two‐centre study.
المؤلفون: Wade, Christine A., Atkinson, Naomi, Holmes, Natasha E., Hui, Lisa
المصدر: Australian & New Zealand Journal of Obstetrics & Gynaecology; Aug2024, Vol. 64 Issue 4, p354-360, 7p
مصطلحات موضوعية: MATERNAL health services, FETAL growth retardation, IMMUNOGLOBULINS, POLYMERASE chain reaction, THIRD trimester of pregnancy, PRENATAL diagnosis, RETROSPECTIVE studies, DESCRIPTIVE statistics, CHI-squared test, MEDICAL records, ACQUISITION of data, CONFIDENCE intervals, AMNIOTIC liquid, DATA analysis software, COMPARATIVE studies, GENETIC testing
مصطلحات جغرافية: AUSTRALIA
مستخلص: Objective: The aim of this study was to evaluate the indications for maternal TORCH (Toxoplasma gondii, rubella, cytomegalovirus (CMV), and herpes simplex virus (HSV)) serology, with a focus on the yield in isolated fetal growth restriction (FGR). Materials and Methods: A retrospective review of antenatal TORCH testing between January 2014 and December 2018 was carried out at two hospitals in Melbourne, Australia. TORCH testing ordered for pregnancy losses and stillbirth was excluded. Results: Medical records of 718 pregnancies were reviewed, representing 760 fetuses. Isolated FGR was the indication for TORCH screening in 71.2% of pregnancies. Screens ordered for isolated FGR were positive in 7.4% (95% CI 5.5–10.0%). There were 49 positive maternal immunoglobulin M (CMV = 34, Toxoplasma = 15). Two acute maternal infections during pregnancy were diagnosed (CMV = 1, Toxoplasma = 1), with both screens ordered to assess symptomatic maternal illness. There was one neonatal CMV infection, born to a woman with symptomatic primary CMV. No maternal or neonatal rubella or HSV infections were identified. We found a diagnostic yield of TORCH screening for isolated FGR of 0.0% (95% CI 0.00–0.8%). An estimated AUD$64 269.75 was expended on maternal TORCH screens in this study. Conclusion: Maternal TORCH testing for isolated FGR is of no diagnostic yield and should be abandoned. [ABSTRACT FROM AUTHOR]
Copyright of Australian & New Zealand Journal of Obstetrics & Gynaecology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00048666
DOI:10.1111/ajo.13802